Literature DB >> 35487975

Deciphering the acetylation code of p53 in transcription regulation and tumor suppression.

Zhangchuan Xia1, Ning Kon1, Alyssa P Gu1, Omid Tavana1, Wei Gu2,3.   

Abstract

Although it is well-established that p53-mediated tumor suppression mainly acts through its ability in transcriptional regulation, the molecular mechanisms of this regulation are not completely understood. Among a number of regulatory modes, acetylation of p53 attracts great interests. p53 was one of the first non-histone proteins found to be functionally regulated by acetylation and deacetylation, and subsequent work has established that reversible acetylation is a general mechanism for regulation of non-histone proteins. Unlike other types of posttranslational modifications occurred during stress responses, the role of p53 acetylation has been recently validated in vivo by using the knock-in mice with both acetylation-defective and acetylation-mimicking p53 mutants. Here, we review the role of acetylation in p53-mediated activities, with a focus on which specific acetylation sites are critical for p53-dependent transcription regulation during tumor suppression and how acetylation of p53 recruits specific "readers" to execute its promoter-specific regulation of different targets. We also discuss the role of p53 acetylation in differentially regulating its classic activities in cell cycle arrest, senescence and apoptosis as well as newly identified unconventional functions such as cell metabolism and ferroptosis.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35487975      PMCID: PMC9149126          DOI: 10.1038/s41388-022-02331-9

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  131 in total

1.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.

Authors:  Stephanie Carter; Oliver Bischof; Anne Dejean; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2007-03-18       Impact factor: 28.824

3.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Authors:  Liz J Valente; Daniel H D Gray; Ewa M Michalak; Josefina Pinon-Hofbauer; Alex Egle; Clare L Scott; Ana Janic; Andreas Strasser
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

Review 4.  Deconstructing networks of p53-mediated tumor suppression in vivo.

Authors:  Alyssa M Kaiser; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

5.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.

Authors:  Sebastian Doll; Bettina Proneth; Yulia Y Tyurina; Elena Panzilius; Sho Kobayashi; Irina Ingold; Martin Irmler; Johannes Beckers; Michaela Aichler; Axel Walch; Holger Prokisch; Dietrich Trümbach; Gaowei Mao; Feng Qu; Hulya Bayir; Joachim Füllekrug; Christina H Scheel; Wolfgang Wurst; Joel A Schick; Valerian E Kagan; José Pedro Friedmann Angeli; Marcus Conrad
Journal:  Nat Chem Biol       Date:  2016-11-14       Impact factor: 15.040

6.  CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.

Authors:  D M Scolnick; N H Chehab; E S Stavridi; M C Lien; L Caruso; E Moran; S L Berger; T D Halazonetis
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

7.  Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses.

Authors:  Le Jiang; Justin H Hickman; Shang-Jui Wang; Wei Gu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  p53 modifications: exquisite decorations of the powerful guardian.

Authors:  Yanqing Liu; Omid Tavana; Wei Gu
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

Review 9.  Shifting the paradigms for tumor suppression: lessons from the p53 field.

Authors:  Thibaut Barnoud; Alexandra Indeglia; Maureen E Murphy
Journal:  Oncogene       Date:  2021-06-08       Impact factor: 9.867

10.  Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells.

Authors:  Xian-Yong Ma; Jian-Hui Wang; Jing-Lan Wang; Charles X Ma; Xiao-Chun Wang; Feng-Song Liu
Journal:  BMC Genomics       Date:  2015-09-03       Impact factor: 3.969

View more
  3 in total

1.  Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation.

Authors:  Yei-Jin Kang; Won-Geun Yang; Weon-Sik Chae; Dae-Won Kim; Seong-Gon Kim; Horatiu Rotaru
Journal:  Oncol Rep       Date:  2022-07-20       Impact factor: 4.136

2.  Mutant p53K120R expression enables a partial capacity to modulate metabolism.

Authors:  Paola Monti; Silvia Ravera; Andrea Speciale; Irena Velkova; Giorgia Foggetti; Paolo Degan; Gilberto Fronza; Paola Menichini
Journal:  Front Genet       Date:  2022-09-26       Impact factor: 4.772

Review 3.  Metabolite-derived protein modifications modulating oncogenic signaling.

Authors:  Yawen Liu; Anke Vandekeere; Min Xu; Sarah-Maria Fendt; Patricia Altea-Manzano
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.